Merck sends $125m to partner Moderna · Articles · Global Corporate Venturing
GCV Asia Congress 2018
Skip Content

8 May 2018

Merck sends $125m to partner Moderna

Three months after raising $500m in a series G round, Moderna Therapeutics has secured $125m as part of a collaboration agreement with Merck & Co.

Author: Thierry Heles, Reporter

US-based RNA-based vaccine developer Moderna Therapeutics has received $125m in series H funding from pharmaceutical firm Merck & Co as part of an expanded collaboration agreement.